Adapting pharmacoeconomic data and methods to extend the postpublication utility of analyses.
作者信息
Lyles Alan
出版信息
Clin Ther. 2009 Jan;31(1):192-3. doi: 10.1016/j.clinthera.2009.01.008.
Abstract
摘要
相似文献
1
Adapting pharmacoeconomic data and methods to extend the postpublication utility of analyses.
Clin Ther. 2009 Jan;31(1):192-3. doi: 10.1016/j.clinthera.2009.01.008.
2
[Methodology of pharmacoeconomic studies in oncology].[肿瘤学中药效经济学研究方法]
Recenti Prog Med. 2008 Jan;99(1):42-7.
3
[Pharmacoeconomic aspects of burn therapies].烧伤治疗的药物经济学方面
Ann Pharm Fr. 2002 Jul;60(4):260-7.
4
[Impact and applicability of the system of reference prices].[参考价格体系的影响与适用性]
Aten Primaria. 2001 Sep 30;28(5):340-8. doi: 10.1016/s0212-6567(01)70386-1.
5
The real world calls. Evolving operationalization of standards by users.现实世界在召唤。用户对标准的操作性不断演变。
Med Care. 1996 Dec;34(12 Suppl):DS173-5.
6
Pharmaceutical industry financial performance.制药行业财务表现。
Nat Rev Drug Discov. 2009 Dec;8(12):927-8. doi: 10.1038/nrd3049.
7
Economic model shows savings through finer dosing increments.经济模型显示，通过更精细的剂量增量可实现节约。
Manag Care Interface. 2005;Suppl:10-1.
8
Can pharmacoeconomic guidelines be implemented successfully in Asia?药物经济学指南能在亚洲成功实施吗？
J Med Econ. 2008;11(2):341-3. doi: 10.3111/13696990802221171.
9
Rational formulary decision making: is drug classification rational?合理的处方集决策：药物分类合理吗？
Value Health. 2003 Mar-Apr;6(2):175-6. doi: 10.1046/j.1524-4733.2003.00004.x.
10
Current pharmacoeconomic issues in Japanese healthcare.日本医疗保健领域当前的药物经济学问题。
Pharmacoeconomics. 1994 Sep;6(3):193-5. doi: 10.2165/00019053-199406030-00002.
Zotero 插件